" class="no-js "lang="en-US"> Mike de Leeuw - Medtech Alert
Thursday, March 28, 2024
Mike de Leeuw

Mike de Leeuw

About Mike de Leeuw

I am passionate about making healthcare technology beneficial for patients and doctors alike, and affordable for societies… I focus on Oncology; seen too many people around me succumb.
In the past 14 years I have started up 3 companies in localized and sustained drug delivery for Cancer, Diabetes, CNS and Orthopaedics. Together my teams and I initiated and raised over euro 120 million for high tech investments in biomedical businesses and public-private fundings.

In the coming years I dedicate myself to my company OncoLize. I will make sure we get proper funding and empower the teams and the partnerships worldwide so that we can unleash the magnificent potential that localized delivery of drugs can do for tumor eradication.

I have a strong, successful track record in turning around, expanding and starting up high tech businesses in DSM, SHELL and start-up’s, in EU and China.

Current Industries: Drug Delivery – Cell Therapy – Regenerative Medicine – Biomedical Materials
Past industries: Performance Materials, Pharma Actives, Bio-energy, Food.
MNC’s: Unilever, SHELL, DSM
SME’s: OncoLize, Hy2Care, InGell Labs, Branching Tree, Beta Cell, Isotis Orthobiology, ACSBiomarker.
Countries: EU – China – India – USA
Settings: Start-up’s (3); JV’s (2); turn-around’s (4); accelerate (2); Asia (2).
Style: Understand the options – Choose and focus – Unleash energy – Reward.
Training: Tumor Virology/ molecular biology (1985 – Univ Leiden, NL) – Business Administration (1984, Erasmus univ, NL) – 1996, IMD Lausanne)

Love to play modern music, sailing, snowboarding, gymnastics… and to cook on Sundays for my family.

Related Story

MyLife Technologies Raises US$4.0 Million to Further Develop its Vaccine Delivery Technology Through Painless Ceramic Vaccine Patches for 'Pandemic Preparedness'

November 12 2021

MyLife Technologies, a Dutch vaccine and drug delivery company, focusing on the development of ceramic […]